Anti-PD-1/PD-L1 agents
Showing 9976 - 10000 of >10,000
Peripheral T Cell Lymphoma Trial in Zhengzhou (Golidocitinib, CHOP Regimen)
Not yet recruiting
- Peripheral T Cell Lymphoma
- Golidocitinib
- CHOP Regimen
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 18, 2023
Airway Obstruction, Snoring, Sedation Complication Trial in Chicago (Anti-snoring device, No anti -snoring device during their
Recruiting
- Airway Obstruction
- +2 more
- Anti-snoring device
- No anti -snoring device during their procedure.
-
Chicago, IllinoisNorthwestern Memorial Hospital and Prentice Women's Hospital
Mar 6, 2023
Healthy Trial in Houston (Placebo, AV-101 720 mg, AV-101 1440 mg)
Completed
- Healthy
- Placebo
- +2 more
-
Houston, TexasMichael E. DeBakey VA Medical Center
Feb 16, 2022
Pneumonia, Viral Trial in Reus, Barcelona, Madrid (radiation, drug, device)
Recruiting
- Pneumonia, Viral
- Low-dose radiotherapy
- +7 more
-
Reus, Tarragona, Spain
- +2 more
Jul 29, 2021
Potential Chemoprevention Drugs in Recurrent Hepatocellular
Recruiting
- Hepatocellular Carcinoma Recurrent
- Surgery
- No intervention for research purpose
-
Taichung, TaiwanChina Medical University Hospital, Department of Surgery
Aug 5, 2023
ST Elevation Myocardial Infarction, Colchicine, Cardiac Remodeling, Ventricular Trial in Jember (drug, procedure, other)
Recruiting
- ST Elevation Myocardial Infarction
- +2 more
- Colchicine
- +2 more
-
Jember, Jawa Timur, IndonesiaRSD dr Soebandi
Jan 23, 2023
MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Adelaide, Australia
- +11 more
Oct 13, 2022
Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)
Completed
- Choroidal Neovascularization
-
Sao Paulo, BrazilHospital das Clínicas- University of Sao Paulo
Jan 4, 2022
Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1
Active, not recruiting
- Ann Arbor Stage I Grade 1 Follicular Lymphoma
- +3 more
- Clinical Observation
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)
Recruiting
- Solid Tumor
- +10 more
-
Belfast, United Kingdom
- +25 more
Mar 28, 2023
Type 1 Diabetes Trial in Málaga (Toujeo SoloStar, Tresiba, Humalog Kwikpen)
Completed
- Type 1 Diabetes Mellitus
- Toujeo SoloStar
- +4 more
-
Málaga, SpainRegional University Hospital of Málaga
Nov 23, 2021
Gastric Cancer, Gastroesophageal Junction Cancer Trial in China (Pembrolizumab, Placebo, Cisplatin)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Cancer
- Pembrolizumab
- +7 more
-
Beijing, Beijing, China
- +12 more
Aug 17, 2022
Patient-Specific Genotypes and Phenotypes That Influence Drug
Enrolling by invitation
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
ECP Combination Study
Active, not recruiting
- Steroid Refractory GVHD
- Ruxolitinib
- +2 more
-
Antwerp, Belgium
- +37 more
Jun 17, 2022
Advanced Non Squamous NSCLC Trial in Beijing (Camrelizumab, Apatinib)
Recruiting
- Advanced Non Squamous NSCLC
-
Beijing, Beijing, ChinaChina
Jun 27, 2021
Resistance Training, Yoga Trial in Coral Gables (Yoga, High-speed Resistance Training)
Recruiting
- Resistance Training
- Yoga
- Yoga
- High-speed Resistance Training
-
Coral Gables, FloridaLaboratory of Neruomuscular Research and Active Aging
Aug 22, 2022
Metastatic Solid Tumors, Locally Advanced Solid Tumors Trial in Taiwan, United States (OBI-888, Globo H IHC Assay)
Terminated
- Metastatic Solid Tumors
- Locally Advanced Solid Tumors
- OBI-888
- Globo H IHC Assay
-
La Jolla, California
- +8 more
Jul 5, 2022
Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant, Avelumab)
Active, not recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Miami, Florida
- +21 more
Mar 18, 2022
CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor -
Recruiting
- Cystic Fibrosis
- Elexacaftor / Ivacaftor / Tezacaftor
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlange, Department of Pediatrics
Oct 7, 2022